title: SME-2-producing Serratia marcescens isolate from Switzerland.
authors.forename: Laurent
authors.initials: L
authors.lastname: Poirel
authors.forename: Aline
authors.initials: A
authors.lastname: Wenger
authors.forename: Jacques
authors.initials: J
authors.lastname: Bille
authors.forename: Sandrine
authors.initials: S
authors.lastname: Bernabeu
authors.forename: Thierry
authors.initials: T
authors.lastname: Naas
authors.forename: Patrice
authors.initials: P
authors.lastname: Nordmann
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D016868:Serratia Infections / Q000382:microbiology; D012706:Serratia marcescens / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification*; D013557:Switzerland; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D001618:beta-Lactamases